CHIP-associated mutations release cfDNA into the bloodstream, which may have similar mutations to tumour-derived cfDNA, potentially leading to false-positive results in cfDNA testing and reducing the specificity of cfDNA testing, which can confound cfDNA test results and lead to misdiagnosis or missed diagnosis. This evidence concerns the gene STUB1 and neoplasm.